Bengt Ågerup

Title: The Innovations of Bengt Ågerup

Introduction

Bengt Ågerup is a notable inventor based in Paris, France. He has made significant contributions to the field of medical technology, particularly in soft tissue augmentation and ocular treatments. With a total of four patents to his name, Ågerup's work has had a profound impact on medical practices.

Latest Patents

One of Ågerup's latest patents is a method of soft tissue augmentation involving injectable gel particles made of a viscoelastic medium. These particles range in size from 1 to 5 mm when subjected to a physiological salt solution. The implant created from these particles is designed for subepidermal administration in mammals, including humans, where soft tissue augmentation is desired. Another significant patent involves the use of a viscoelastic composition for treating increased intraocular pressure. This composition is useful for manufacturing a medicament that can be administered into sclerally penetrating fistulas in the eye, effectively treating conditions related to elevated intraocular pressure.

Career Highlights

Throughout his career, Bengt Ågerup has worked with prominent companies in the medical field. Notably, he has been associated with Q-Med AB and Galderma Holding SA. His experience in these organizations has allowed him to develop innovative solutions that address critical medical challenges.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Bengt Ågerup's contributions to medical technology through his patents and career experiences highlight his role as an influential inventor. His work continues to shape advancements in soft tissue augmentation and ocular treatments, benefiting both humans and animals.